By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Uptake Medical 

2028 5th Avenue
Suite 204
Seattle  Washington  98121  U.S.A.
Phone: 206-859-4555 Fax: 206-859-4557


Medical Device

Company News
Uptake Medical Announces First-In-Human Lung Cancer Tumor Ablation Using Intervapor Targeted Vapor Therapy 10/12/2015 8:25:10 AM
Data Confirms Uptake Medical’s InterVapor Significantly Improves Lung Function in Severe Emphysema Patients 10/2/2015 7:57:27 AM
Uptake Medical Receives CE Mark Approval For InterVapor Targeted Ablation Therapy For Severe Emphysema 8/12/2015 11:07:20 AM
Uptake Medical Announces Positive 12-month Outcome Data for InterVapor Therapy for Severe Emphysema 5/24/2012 10:57:09 AM
Uptake Medical Announces Successful Completion of Series C Financing 1/9/2012 11:44:37 AM
Uptake Medical Raises $35 Million Cash for Novel Emphysema Treatment 1/4/2012 9:00:18 AM
Uptake Medical Announces TGA Approval of InterVapor for Patients With Severe Emphysema 12/21/2011 10:30:01 AM
Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema 11/29/2011 12:12:50 PM
Uptake Medical Receives CE Mark for InterVapor - Endoscopic Lung Volume Reduction for Treatment of Severe Emphysema - and Announces Positive Clinical Results 9/26/2011 7:06:40 AM
Uptake Medical Expands Executive Team, Announces European General Manager Lloyd Mencinger 9/6/2011 11:30:04 AM